March 24, 2022 01:20 PM EDT
Pharma
Manufacturing

Mer­ck to stop mak­ing APIs at Penn­syl­va­nia site and cut 300 jobs by 2024

Josh Sullivan

In 2024, Mer­ck will dis­con­tin­ue its man­u­fac­tur­ing of ac­tive phar­ma­ceu­ti­cal in­gre­di­ents. And with that move, it will no longer need its Chero­kee man­u­fac­tur­ing site in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

A service from the Financial Times